Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki(The University of Texas Medical Branch at Galveston), Gulshan Sharma(Lovely Professional University), Shawn PE Nishi, Bill T. Ameredes(National Institutes of Health)
Cited by 6
Related Papers
Effect of aging on respiratory system physiology and immunology
|Clinical Interventions in Aging|2006|1k
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program
|Journal of Allergy and Clinical Immunology|2007|933
A review on municipal solid waste as a renewable source for waste-to-energy project in India: Current practices, challenges, and future opportunities
|Journal of Cleaner Production|2020|401
Outpatient Follow-up Visit and 30-Day Emergency Department Visit and Readmission in Patients Hospitalized for Chronic Obstructive Pulmonary Disease
|Archives of Internal Medicine|2010|263
Growth in the Care of Older Patients by Hospitalists in the United States
|New England Journal of Medicine|2009|242